Clinical trials recruiting in Saint-Brieuc, France
7
Recruiting trials
14
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 2Not applicable 4
Conditions recruiting in Saint-Brieuc, France
Recruiting trials in Saint-Brieuc, France
- A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors
- REBECCA Real-world Early BrEast CanCer mAnagement
- UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
Common questions
How many clinical trials are recruiting in Saint-Brieuc, France?
7 recruiting trials have at least one study site in Saint-Brieuc, France.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.